Radiopharm Theranostics Limited (ASX:RAD)
Australia
· Delayed Price · Currency is AUD 0.0220
+0.0010 (4.76%)
Apr 28, 2025, 4:10 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 51.35 million as of April 25, 2025. Its market cap has increased by 130.71% in one year.
Market Cap
51.35M
Enterprise Value
13.71M
Revenue
330.63K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 51.35M, a decrease of -49.33%. That is a compound annual growth rate of -18.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 49.01M | -6.90% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 117.13B |
| Pro Medicus | 22.02B |
| Cochlear | 17.31B |
| Sonic Healthcare | 12.25B |
| Telix Pharmaceuticals | 9.65B |
| Ramsay Health Care | 7.63B |
| Ansell | 4.26B |
| Mesoblast | 2.29B |